Allergy Therapeutics Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
602
- Stock Symbol
-
AGY
- Investments
-
3
- Share Price
-
$0.09
- (As of Friday Closing)
Allergy Therapeutics General Information
Description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany, Austria, Netherlands, and Switzerland.
Contact Information
Website
www.allergytherapeutics.comCorporate Office
- Dominion Way
- West Sussex
- Worthing BN14 8SA
- England, United Kingdom
Corporate Office
- Dominion Way
- West Sussex
- Worthing BN14 8SA
- England, United Kingdom
Allergy Therapeutics Stock Performance
As of 14-Mar-2025, Allergy Therapeutics’s stock price is $0.09. Its current market cap is $432M with 4.77B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.09 | $0.09 | $0.03 - $0.10 | $432M | 4.77B | 407K | -$0.01 |
Allergy Therapeutics Financials Summary
As of 30-Jun-2024, Allergy Therapeutics has a trailing 12-month revenue of $69.5M.
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
|---|---|---|---|---|
| EV | 311,140 | 311,140 | 2,432 | 119,625 |
| Revenue | 69,498 | 69,498 | 71,666 | 96,761 |
| EBITDA | (39,062) | (39,062) | (42,612) | (10,739) |
| Net Income | (50,634) | (50,634) | (51,802) | (18,318) |
| Total Assets | 81,993 | 81,993 | 84,216 | 88,478 |
| Total Debt | 39,194 | 39,194 | 45,393 | 12,770 |
Allergy Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Allergy Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Allergy Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Allergy Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Allergy Therapeutics Investments & Acquisitions (3)
Allergy Therapeutics’s most recent deal was a Corporate Asset Purchase with Allergy Therapeutics (VLP Platform). The deal was made on 30-Sep-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Allergy Therapeutics (VLP Platform) | 30-Sep-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Alerpharma | 05-Jun-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Bencard | 01-Jul-2010 | Merger/Acquisition | Distributors (Healthcare) |
Allergy Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Allergy Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bencard | Greifensee, Switzerland | 1989 |
Allergy Therapeutics FAQs
-
When was Allergy Therapeutics founded?
Allergy Therapeutics was founded in 1998.
-
Where is Allergy Therapeutics headquartered?
Allergy Therapeutics is headquartered in Worthing, United Kingdom.
-
What is the size of Allergy Therapeutics?
Allergy Therapeutics has 602 total employees.
-
What industry is Allergy Therapeutics in?
Allergy Therapeutics’s primary industry is Other Commercial Services.
-
Is Allergy Therapeutics a private or public company?
Allergy Therapeutics is a Public company.
-
What is Allergy Therapeutics’s stock symbol?
The ticker symbol for Allergy Therapeutics is AGY.
-
What is the current stock price of Allergy Therapeutics?
As of 14-Mar-2025 the stock price of Allergy Therapeutics is $0.09.
-
What is the current market cap of Allergy Therapeutics?
The current market capitalization of Allergy Therapeutics is $432M.
-
What is Allergy Therapeutics’s current revenue?
The trailing twelve month revenue for Allergy Therapeutics is $69.5M.
-
What is Allergy Therapeutics’s annual earnings per share (EPS)?
Allergy Therapeutics’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
